Onkure Therapeutics Inc (OKUR)

Jun 08, 2025

Two Sigma Advisers LP Invests $122,000 in OnKure Therapeutics (NASDAQ:OKUR) - Defense World

Jun 08, 2025

Jun 05, 2025

Millennium Management LLC Acquires New Shares in OnKure Therapeutics (NASDAQ:OKUR) - Defense World

Jun 05, 2025

Jun 04, 2025

Northern Trust Corp Purchases New Position in OnKure Therapeutics (NASDAQ:OKUR) - Defense World

Jun 04, 2025

Jun 03, 2025

Buy Rating for OnKure Therapeutics Driven by Promising Developments in Metastatic Breast Cancer Treatment and Strong Financial Position - TipRanks

Jun 03, 2025

Jun 03, 2025

Bank of America Corp DE Takes $2.15 Million Position in OnKure Therapeutics (NASDAQ:OKUR) - Defense World

Jun 03, 2025

May 28, 2025

OnKure Elects Directors at Annual Stockholder Meeting - TipRanks

May 28, 2025

May 25, 2025

OnKure Therapeutics (NASDAQ:OKUR) Given Consensus Recommendation of “Buy” by Analysts - Defense World

May 25, 2025

May 19, 2025

Major Stakeholders Shuffle Shares in OnKure Therapeutics - TipRanks

May 19, 2025

May 17, 2025

OnKure Therapeutics Inc (OKUR) At $2.00 Is Well Worth Your Time - Stocksregister

May 17, 2025

May 15, 2025

Barclays PLC Purchases New Stake in OnKure Therapeutics (NASDAQ:OKUR) - Defense World

May 15, 2025

May 14, 2025

Major Shareholder Sells Thousands of OnKure Therapeutics Shares! - TipRanks

May 14, 2025

May 10, 2025

Leerink Partnrs Issues Optimistic Outlook for OKUR Earnings - Defense World

May 10, 2025

May 09, 2025

Promising Developments and Positive Trial Results Reinforce Buy Rating for OnKure Therapeutics - TipRanks

May 09, 2025

May 07, 2025

OnKure increased R&D spending in 1Q with drug trials underway - BizWest

May 07, 2025

May 07, 2025

OnKure Therapeutics Reports Q1 2025 Progress and Financials - TipRanks

May 07, 2025

May 06, 2025

Form 424B3 OnKure Therapeutics, - StreetInsider

May 06, 2025

May 06, 2025

OnKure Therapeutics Reports Progress in PIKture-01 Trial and Financial Results for Q1 2025 - Nasdaq

May 06, 2025

May 06, 2025

OnKure Therapeutics, Inc. SEC 10-Q Report - TradingView

May 06, 2025

May 06, 2025

OnKure Therapeutics Reports First Quarter 2025 Financial Results and Business Highlights - GlobeNewswire

May 06, 2025

May 06, 2025

Head to Head Contrast: OnKure Therapeutics (NASDAQ:OKUR) & Anebulo Pharmaceuticals (NASDAQ:ANEB) - Defense World

May 06, 2025

May 05, 2025

Renaissance Technologies LLC Invests $408,000 in OnKure Therapeutics (NASDAQ:OKUR) - Defense World

May 05, 2025

May 04, 2025

OnKure Therapeutics (OKUR) Projected to Post Earnings on Tuesday - Defense World

May 04, 2025

May 03, 2025

OnKure Therapeutics (NASDAQ:OKUR) Research Coverage Started at Evercore ISI - Defense World

May 03, 2025

May 03, 2025

OnKure Therapeutics (NASDAQ:OKUR) Receives $32.33 Average Price Target from Brokerages - Defense World

May 03, 2025

May 02, 2025

Geode Capital Management LLC Makes New $659,000 Investment in OnKure Therapeutics (NASDAQ:OKUR) - Defense World

May 02, 2025

May 02, 2025

Q1 Earnings Estimate for OKUR Issued By Leerink Partnrs - Defense World

May 02, 2025

Apr 30, 2025

OnKure Therapeutics initiated with an Outperform at Evercore ISI - TipRanks

Apr 30, 2025

Apr 30, 2025

Evercore ISI Initiates Coverage on OnKure Therapeutics With Outperform Rating - marketscreener.com

Apr 30, 2025

Apr 30, 2025

Evercore ISI starts OnKure stock with Outperform rating - Investing.com

Apr 30, 2025

Apr 30, 2025

Evercore ISI starts OnKure stock with Outperform rating By Investing.com - Investing.com India

Apr 30, 2025

Apr 28, 2025

OKUR stock touches 52-week low at $2.49 amid market challenges - Investing.com

Apr 28, 2025

Apr 10, 2025

OnKure Therapeutics CEO sells $2,569 in stock - Investing.com Australia

Apr 10, 2025

Apr 08, 2025

OnKure Therapeutics CFO sells $9,177 in stock By Investing.com - Investing.com South Africa

Apr 08, 2025

Apr 08, 2025

OnKure Therapeutics CEO sells $2,569 in stock By Investing.com - Investing.com India

Apr 08, 2025

Apr 08, 2025

OnKure Therapeutics CFO sells $9,177 in stock - Investing.com

Apr 08, 2025

Apr 05, 2025

OKUR stock touches 52-week low at $3.39 amid market challenges - Investing.com Canada

Apr 05, 2025

Apr 04, 2025

OKUR stock touches 52-week low at $3.39 amid market challenges By Investing.com - Investing.com South Africa

Apr 04, 2025

Mar 29, 2025

We're Keeping An Eye On OnKure Therapeutics' (NASDAQ:OKUR) Cash Burn Rate - simplywall.st

Mar 29, 2025

Mar 28, 2025

OKUR stock touches 52-week low at $4.43 amid market challenges - Investing.com Australia

Mar 28, 2025

Mar 28, 2025

OKUR stock touches 52-week low at $4.43 amid market challenges By Investing.com - Investing.com South Africa

Mar 28, 2025

Mar 21, 2025

Q1 EPS Estimate for OnKure Therapeutics Lowered by Analyst - Defense World

Mar 21, 2025

Mar 20, 2025

OnKure Therapeutics (OKUR) Expected to Announce Quarterly Earnings on Thursday - Defense World

Mar 20, 2025

Mar 18, 2025

H.C. Wainwright cuts OnKure Therapeutics price target to $34 By Investing.com - Investing.com Australia

Mar 18, 2025

Mar 18, 2025

Onkure Therapeutics Faces Stiff Competition in the Pharmaceutical Sector: Challenges in Commercializing PI3Ka Therapies - TipRanks

Mar 18, 2025

Mar 18, 2025

H.C. Wainwright cuts OnKure Therapeutics price target to $34 - Investing.com India

Mar 18, 2025

Mar 18, 2025

Promising Outlook for OnKure Therapeutics: Strategic Developments and Market Expansion Plans for 2025 - TipRanks

Mar 18, 2025

Mar 16, 2025

Analyzing Organogenesis (NASDAQ:ORGO) and OnKure Therapeutics (NASDAQ:OKUR) - Defense World

Mar 16, 2025

Mar 15, 2025

OKUR stock touches 52-week low at $4.54 amid market challenges - Investing.com Australia

Mar 15, 2025